Ella Emergency Contraceptive Approved

Intended to inhibit or delay ovulation

Related Encyclopedia • Acidophilus • AIDS and HIV Infection • Amenorrhea • Amniocentesis More... Related Healthscout Videos Stay Flu-Free Forever Gene Screen for Cancer Triggers Cancer: Cure from the Outside-In Pumpkin and Cream Cheese Wontons More... Related Animations • Breast Reduction • Breast Self-Exam Video • Erectile Dysfunction • Facelift More... Related Drug Information • Actonel • Cialis • Detrol LA • Diflucan More... Related News Articles • Fewer U.S. Teens Having Babies, Binge Drinking: Report • Patient Disparities Seen in Lung Cancer Drug Trials • Satisfaction With Life Seems Good for the Heart • U.S. Database of Breast Cancer Treatment May Be Inaccurate More...

MONDAY, Aug. 16 (HealthDay News) -- The ella emergency contraceptive has been approved by the U.S. Food and Drug Administration. It's been available in Europe for more than a year under the brand name ellaOne.

To be taken within five days of contraceptive failure or unprotected intercourse, the drug is not meant to be used as a routine contraceptive, the FDA said in news release. Among a class of drugs called progesterone agonists/antagonists, it's intended to inhibit or delay ovulation.

Text Continues Below

---

Ella's safety and effectiveness were demonstrated in studies conducted in the United States, United Kingdom and Ireland, the agency said. The most common side effects included headache, nausea, abdominal pain, menstrual pain, fatigue and dizziness.

Women with known or suspected pregnancy or those who are breast-feeding shouldn't use ella, the FDA said.

The drug is distributed by Watson Pharma Inc., based in Morristown, N.J.

More information

The FDA has more about this approval.

-- Scott Roberts